Advertisement

Topics

Patent Trials and Appeal Board (PTAB) Upholds Four AMPYRA® Patents

15:43 EST 9 Mar 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Acorda Therapeutics, Inc. (Nasdaq: ACOR ) today announced that the United States Patent and Trademark Office (USPTO) Patent Trials and Appeal Board (PTAB) upheld all four patents challenged via the inter partes review (IPR) pr...

Other Sources for this Article

Acorda Therapeutics
Jeff Macdonald, 914-326-5232
jmacdonald@acorda.com

NEXT ARTICLE

More From BioPortfolio on "Patent Trials and Appeal Board (PTAB) Upholds Four AMPYRA® Patents"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Bioscience
Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...